Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Dow
Healthtrust
Accenture
Boehringer Ingelheim
Teva
Express Scripts
Colorcon
Citi

Generated: April 22, 2018

DrugPatentWatch Database Preview

URISPAS Drug Profile

« Back to Dashboard

When do Urispas patents expire, and when can generic versions of Urispas launch?

Urispas is a drug marketed by Ortho Mcneil Janssen and is included in one NDA.

The generic ingredient in URISPAS is flavoxate hydrochloride. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the flavoxate hydrochloride profile page.
Summary for URISPAS
Drug patent expirations by year for URISPAS
Medical Subject Heading (MeSH) Categories for URISPAS
Synonyms for URISPAS
1-(2-{[(3-methyl-4-oxo-2-phenyl-4H-chromen-8-yl)carbonyl]oxy}ethyl)piperidinium chloride
1-Piperidinoethanol, hydrochloride
2-(1-piperidyl)ethyl 3-methyl-4-oxo-2-phenyl-chromene-8-carboxylate hydrochloride
2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride
2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate hydrochloride
2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate;hydrochloride
2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate hydrochloride
2-Piperidinoethyl-3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate hydrochloride
27814-EP2269989A1
27814-EP2298767A1
27814-EP2298772A1
27814-EP2308839A1
27814-EP2314587A1
3-Methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid 2-(1-piperidinyl)ethyl ester hydrochloride
3-Methyl-4-oxo-2-phenyl-4H-benzopyran-8-carboxylic acid 2-piperidinyl ethyl ester
3717-88-2
4H-1-Benzopyran-8-carboxylic acid, 2-(1-piperidinyl)ethyl ester, hydrochloride
4H-1-Benzopyran-8-carboxylic acid, 2-piperidinoethyl ester, hydrochloride
9C05J6089W
AB0011722
AC-1093
AC1L9B0J
ACM1189678430
AKOS025310107
AN-15251
ANW-43270
AOB5638
API0002707
AS-12321
BC222362
Bladderon
C-34896
C24H26ClNO4
CAS-3717-88-2
CC-28434
CCG-220242
CHEBI:5089
CHEMBL1200875
CS-2652
CTK8B3835
D00718
DSSTox_CID_27764
DSSTox_GSID_47784
DSSTox_RID_82541
DTXSID1047784
DW 61 (flavoxate)
DW-61
DW-61;Rec-7-0040;DW61
F0717
Flavoxate hydrochloride
Flavoxate (hydrochloride)
Flavoxate HCL
Flavoxate hydrochloride
Flavoxate hydrochloride (JP17/USAN)
Flavoxate hydrochloride [USAN:USP:JAN]
Flavoxate hydrochloride, >=98% (HPLC), solid
Flavoxate hydrochloride, European Pharmacopoeia (EP) Reference Standard
Flavoxate hydrochloride, United States Pharmacopeia (USP) Reference Standard
FT-0658191
FT-0668549
HMS1568B06
HY-B0549A
J-521367
J10335
KS-00000XSH
MFCD00072099
MLS002154247
MolPort-003-986-802
NCGC00016636-01
NCGC00016636-05
NSC-114649
NSC114649
Peflate
Piperidinoethyl-3-methylflavone-8-carboxylate hydrochloride
Prestwick_884
Rec 7/0040
Rec-7-0040
RL03419
s4027
SCHEMBL124540
SMR000499576
Spasmal
TL8002737
Tox21_110537
Tox21_110537_1
TR-015131
UNII-9C05J6089W
Verrispasmin amp.
WLN: T66 BO EVJ CR& D1 JVO2- AT6NTJ &GH

US Patents and Regulatory Information for URISPAS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ortho Mcneil Janssen URISPAS flavoxate hydrochloride TABLET;ORAL 016769-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Daiichi Sankyo
Farmers Insurance
Covington
McKesson
Queensland Health
Julphar
US Army
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.